Convatec to reprice as CPA smells success
US wound therapy company Convatec is attempting to slice 25bp-50bp off its €532m euro-denominated term loan ‘B’, just one month after reducing the margins on its US dollar-denominated tranche to 375bp.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
